NewEdge Advisors’s Repligen RGEN Stock Holding History

NewEdge Advisors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.96K	Buy	51 +1	+2%	+$123	﹤0.01%	3633
2026 Q1	$5.89K	Buy	+50	New	+$6.99K	﹤0.01%	3539
2024 Q2	–	Sell	-54	Closed	-$9.93K	–	3974
2024 Q1	$9.93K	Sell	54 -35	-39%	-$6.67K	﹤0.01%	2885
2023 Q4	$16K	Sell	89 -1,769	-95%	-$275K	﹤0.01%	2667
2023 Q3	$295K	Buy	1,858 +1,771	+2,036%	+$290K	﹤0.01%	1434
2023 Q2	$12.3K	Buy	87 +5	+6%	+$802	﹤0.01%	2542
2023 Q1	$13.8K	Sell	82 -246	-75%	-$43.9K	﹤0.01%	2472
2022 Q4	$34.9K	Buy	+328	New	+$59.5K	﹤0.01%	1879

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

NewEdge Advisors's RGEN Position: Q2 2026 in Review

NewEdge Advisors increased its Repligen (RGEN) stake by 2% in Q2 2026, buying an estimated $123 and bringing the position to 51 shares worth $6.96K. The position accounts for ﹤0.01% of the portfolio, ranked #3633.

NewEdge Advisors first reported a position in RGEN in Q4 2022 and has held it in 8 quarters since. The position peaked at $295K in Q3 2023. 481 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.

NewEdge Advisors held 51 shares of Repligen worth $6.96K as of Q2 2026.
NewEdge Advisors bought 1 Repligen share in Q2 2026, an estimated $123.
Repligen made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3633 holding.
NewEdge Advisors first reported a position in Repligen in Q4 2022 and has held it in 8 quarters since.
NewEdge Advisors's Repligen position peaked at $295K in Q3 2023.
481 funds tracked by Wall St. Rank held Repligen as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.